High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome.
<h4>Background</h4>Currently, there are few treatment-predictive and prognostic biomarkers in triple-negative breast cancer (TNBC). Caveolin-1 (CAV1) is linked to chemoresistance and several important processes involved in tumor progression and metastasis, such as epithelial-mesenchymal...
Saved in:
| Main Authors: | Christopher Godina, Somayeh Khazaei, Mattias Belting, Johan Vallon-Christersson, Björn Nodin, Karin Jirström, Karolin Isaksson, Ana Bosch, Helena Jernström |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0305222 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
by: Annelie Augustinsson, et al.
Published: (2025-07-01) -
Caveolin 1 expression favors tumor growth and is associated with poor survival in primary lung adenocarcinomas
by: Eleonora Duregon, et al.
Published: (2017-02-01) -
Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases
by: Wladimir Gerstenberger, et al.
Published: (2018-01-01) -
Prediction of gene expression-based breast cancer proliferation scores from histopathology whole slide images using deep learning
by: Andreas Ekholm, et al.
Published: (2024-12-01) -
Caveolae and caveolins role in health and disease
by: R. I. Voroblev, et al.
Published: (2008-12-01)